Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (3s,4ar,6r,8ar)-6-(2-(1(2)h-tetrazole-5yl)ethyl)decahydroisoquinoline-3carboxylic Acid
2. 6-(2-(1h-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid
3. Ly 215490
4. Ly 293558
5. Ly 326325
6. Ly-215490
7. Ly-293558
8. Ly-326325
9. Ly293558
10. Ngx424
1. 154652-83-2
2. Tezampanel (anhydrous)
3. Ly-293558
4. Ly293558
5. 150131-78-5
6. Tezampanel [inn]
7. Tezampanel, Anhydrous
8. Ly 293558
9. Ngx-424
10. Ly-293,558
11. 6-(2-(1h-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid
12. Chembl14935
13. Ga36s2o9c2
14. (3s,4ar,6r,8ar)-6-[2-(2h-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic Acid
15. 154652-83-2 (anhydrous)
16. (3s,4ar,6r,8ar)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic Acid
17. Ted-isoquinoline-3-cooh
18. Unii-ga36s2o9c2
19. Ly215490
20. Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-3-isoquinolinecarboxylic Acid
21. Tezampanel Anhydrous
22. Gtpl4245
23. Schembl1649338
24. Bdbm86751
25. Zinc5134714
26. Bdbm50494341
27. Cs-0821
28. Db06354
29. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4ar,6r,8ar)-
30. Ncgc00378884-01
31. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s-(3alpha,4aalpha,6beta,8aalpha))-
32. Hy-75704
33. Q7708612
34. (3s,4ar,6r,8ar)-6-[2-(1h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic Acid
35. (3s,4ar,6r,8ar)-6-[2-(2h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic Acid
36. (3s,4as,6r,8as)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic Acid
37. 3-isoquinolinecarboxylic Acid, Decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4as,6r,8as)-
| Molecular Weight | 279.34 g/mol |
|---|---|
| Molecular Formula | C13H21N5O2 |
| XLogP3 | -0.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 279.16952493 g/mol |
| Monoisotopic Mass | 279.16952493 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 354 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in pain (acute or chronic) and migraine and cluster headaches.
NGX426 is a prodrug of tezampanel (NGX424). Tezampanel is an antagonist that binds to glutamate kainate (Glu K5) receptors, inhibiting excitatory synapases the brain.
ABOUT THIS PAGE
69
PharmaCompass offers a list of Tezampanel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tezampanel manufacturer or Tezampanel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tezampanel manufacturer or Tezampanel supplier.
PharmaCompass also assists you with knowing the Tezampanel API Price utilized in the formulation of products. Tezampanel API Price is not always fixed or binding as the Tezampanel Price is obtained through a variety of data sources. The Tezampanel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tezampanel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tezampanel, including repackagers and relabelers. The FDA regulates Tezampanel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tezampanel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tezampanel supplier is an individual or a company that provides Tezampanel active pharmaceutical ingredient (API) or Tezampanel finished formulations upon request. The Tezampanel suppliers may include Tezampanel API manufacturers, exporters, distributors and traders.
Tezampanel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tezampanel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tezampanel GMP manufacturer or Tezampanel GMP API supplier for your needs.
A Tezampanel CoA (Certificate of Analysis) is a formal document that attests to Tezampanel's compliance with Tezampanel specifications and serves as a tool for batch-level quality control.
Tezampanel CoA mostly includes findings from lab analyses of a specific batch. For each Tezampanel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tezampanel may be tested according to a variety of international standards, such as European Pharmacopoeia (Tezampanel EP), Tezampanel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tezampanel USP).
